New research suggests that dietary changes could outperform traditional drugs in relieving symptoms of irritable bowel ...

Treating patients with irritable bowel syndrome can be a challenge for health care providers, as patients with suspected IBS often report a lengthy list of visceral and somatic symptoms that can ...

Rifaximin is as effective as the low-FODMAP diet in managing irritable bowel syndrome and offers quicker symptom relief and ...

Rimegepant is already FDA-approved for acute treatment of migraine and preventive treatment of episodic migraine in adults. By blocking CGRP -- a neurotransmitter expressed throughout the gut's ...

Dr. Lacy Anderson explains sudden, short-term nausea and vomiting signal a stomach virus, while long-lasting bowel issues ...

Ibsrela (tenapanor) is a prescription drug used to treat irritable bowel syndrome with constipation (IBS-C) in adults. Ibsrela comes as an oral tablet. To learn more about Ibsrela’s uses, see the ...

After 4 weeks of treatment in the modified intention-to-treat population, 76% of participants following a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs ...

Digestive woes like bloating and cramps often lead to confusion between IBS and IBD. While IBS is a functional disorder ...

The new approval that came from the USFDA makes it sure that the Linzess is safe and effective, bringing a sense of relief ...

Patients with inflammatory bowel disease (IBD) may be treated with immunomodulatory drugs such as tumor necrosis factor (TNF) α inhibitors, which potentially induce an increased risk of infection.